Prophylactic pancreatic stent placement and post-ERCP pancreatitis: An updated meta-analysis

Journal of Gastroenterology

Volumn 49, Issue 2, 2014, Pages 343-355

  Mazaki, Takero ^a   Mado, Kazunari ^a   Masuda, Hideki ^a   Shiono, Motomi ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

ERCP; Meta analysis; Pancreatic stent; Post ERCP pancreatitis

Indexed keywords

ARTICLE; CLINICAL EFFECTIVENESS; COCHRANE LIBRARY; CONFIDENCE INTERVAL; EFFECT SIZE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HIGH RISK POPULATION; HUMAN; INCIDENCE; INTENTION TO TREAT ANALYSIS; MEDLINE; META ANALYSIS; OUTCOME ASSESSMENT; PANCREATIC DUCT STENT; PANCREATITIS; POST ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY PACREATITIS; PRIORITY JOURNAL; PROPHYLAXIS; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SENSITIVITY ANALYSIS;

CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; HUMANS; PANCREATIC DUCTS; PANCREATITIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STENTS;

EID: 84896700125     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-013-0806-1     Document Type: Article

References (46)

1. Fogel EL, Eversman D, Jamidar P, Sherman S, Lehman GA. Sphincter of Oddi dysfunction: pancreaticobiliary sphincterotomy with pancreatic stent placement has a lower rate of pancreatitis than biliary sphincterotomy alone. Endoscopy. 2002;34:280-5.
2. Cotton PB, Garrow DA, Gallagher J, Romagnuolo J. Risk factors for complications after ERCP: a multivariate analysis of 11,497 procedures over 12 years. Gastrointest Endosc. 2009;70:80-8.
3. Loperfido S, Angelini G, Benedetti G, Chilovi F, Costan F, De Berardinis F, et al. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc. 1998;48:1-10.
4. Masci E, Toti G, Mariani A, Curioni S, Lomazzi A, Dinelli M, et al. Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol. 2001;96:417-23.
5. Mehta SN, Pavone E, Barkun JS, Bouchard S, Barkun AN. Predictors of post-ERCP complications in patients with suspected choledocholithiasis. Endoscopy. 1998;30:457-63.
6. Vandervoort J, Soetikno RM, Tham TC, Wong RCK, Ferrari AP, Montes H, et al. Risk factors for complications after performance of ERCP. Gastrointest Endosc. 2002;56:652-6.
7. Bai Y, Gao J, Zhang W, Zou D, Li Z. Meta-analysis: allopurinol in the prevention of postendoscopic retrograde cholangiopancreatography pancreatitis. Aliment Pharmacol Ther. 2008;28:557-64.
8. Zheng M, Bai J, Yuan B, Lin F, You J, Lu M, et al. Meta-analysis of prophylactic corticosteroid use in post-ERCP pancreatitis. BMC Gastroenterol. 2007;7:6. doi: 10.1186/1471-230X-8-6
9. Andriulli A, Leandro G, Federici T, Ippolito A, Forlano R, Iacobellis A, et al. Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: an updated meta-analysis. Gastrointest Endosc. 2007;65:624-32.
10. Choi CW, Kang DH, Kim GH, Eum JS, Lee SM, Song GA, et al. Nafamostat mesylate in the prevention of post-ERCP pancreatitis and risk factors for post-ERCP pancreatitis. Gastrointest Endosc. 2009;69:e11-8. doi: 10.1016/j.gie.2008.10.046
11. Zhang Y, Chen QB, Gao ZY, Xie WF. Meta-analysis: octreotide prevents post-ERCP pancreatitis, but only at sufficient doses. Aliment Pharmacol Ther. 2009;29:1155-64.
12. Rudin D, Kiss A, Wetz RV, Sottile VM. Somatostatin and gabexate for post-endoscopic retrograde cholangiopancreatography pancreatitis prevention: meta-analysis of randomized placebo-controlled studies. J Gastroenterol Hepatol. 2007;22:977-83.
13. Elmunzer BJ, Scheiman JM, Lehman GA, Chak A, Mosler P, Higgins PDR, et al. A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. N Engl J Med. 2012;366:1414-22.
14. Fazel A, Quadri A, Catalano MF, Meyerson SM, Geenen JE. Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study. Gastrointest Endosc. 2003;57:291-4.
15. Harewood GC, Pochron NL, Gostout CJ. Prospective, randomized, controlled study of prophylactic pancreatic stent placement for endoscopic snare excision of the duodenal ampulla. Gastrointest Endosc. 2005;62:367-70.
16. Patel R, Tarnasky PR, Hennessy WS, Hawes RH, Payne KM, Nelles SE, et al. Does stenting after pancreatic sphincterotomy reduce post-ERCP pancreatitis in patients with prior biliary sphincterotomy?: Preliminary results of a prospective randomized study (abstract). Gastrointest Endosc. 1999;49:AB80.
17. Sherman S, Bucksot EL, Esber E, Pezzi J, Gottlieb K, Lehman G. Does leaving a main pancreatic duct stent in place reduce the incidence of precut biliary sphincterotomy-induced pancreatitis? Randomized prospective study (abstract). Am J Gastroenterol. 1995;90:241.
18. Smithline A, Silverman W, Rogers D, Nisi R, Wiersema M, Jamidar P, et al. Effect of prophylactic main pancreatic duct stenting on the incidence of biliary endoscopic sphincterotomy-induced pancreatitis in high-risk patients. Gastrointest Endosc. 1993;39:652-7.
19. Sofuni A, Maguchi H, Itoi T, Katanuma A, Hisai H, Niido T, et al. Prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis by an endoscopic pancreatic spontaneous dislodgement stent. Clin Gastroenterol Hepatol. 2007;5:1339-46.
20. Tarnasky PR, Palesch YY, Cunningham JT, Mauldin PD, Cotton PB, Hawes RH. Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction. Gastroenterology. 1998;115:1518-24.
21. Tsuchiya T, Itoi T, Sofuni A, Itokawa F, Kurihara T, Ishii K, et al. Temporary pancreatic stent to prevent post endoscopic retrograde cholangiopancreatography pancreatitis: a preliminary, single-center, randomized controlled study. J Hepatobiliary Pancreat Surg. 2007;14:302-7.
22. Ito K, Fujita N, Noda Y, Kobayashi G, Obana T, Horaguchi J, et al. Can pancreatic duct stenting prevent post-ERCP pancreatitis in patients who undergo pancreatic duct guidewire placement for achieving selective biliary cannulation? A prospective randomized controlled trial. J Gastroenterol. 2010;45:1183-91.
23. Pan XP, Dang T, Meng XM, Xue KC, Chang ZH, Zhang YP. Clinical study on the prevention of post-ERCP pancreatitis by pancreatic duct stenting. Cell Biochem Biophys. 2011;61:473-9.
24. Sofuni A, Maguchi H, Mukai T, Kawakami H, Irisawa A, Kubota K, et al. Endoscopic pancreatic duct stents reduce the incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients. Clin Gastroenterol Hepatol. 2011;9:851-8.
25. Kawaguchi Y, Ogawa M, Omata F, Ito H, Shimosegawa T, Mine T. Randomized controlled trial of pancreatic stenting to prevent pancreatitis after endoscopic retrograde cholangiopancreatography. World J Gastroenterol. 2012;18:1635-41.
26. Cha SW, Leung WD, Lehman GA, Watkins JL, McHenry L, Fogel EL, et al. Does leaving a main pancreatic duct stent in place reduce the incidence of precut biliary sphincterotomy-associated pancreatitis? A randomized, prospective study. Gastrointest Endosc. 2012. doi: 10.1016/j.gie.2012.08.022.
27. Lee TH, Moon JH, Choi HJ, Han SH, Cheon YK, Cho YD, et al. Prophylactic temporary 3F pancreatic duct stent to prevent post-ERCP pancreatitis in patients with a difficult biliary cannulation: a multicenter, prospective, randomized study. Gastrointest Endosc. 2012;76:578-85.
28. Andriulli A, Forlano R, Napolitano G, Conoscitore P, Caruso N, Pilotto A, et al. Pancreatic duct stents in the prophylaxis of pancreatic damage after endoscopic retrograde cholangiopancreatography: a systematic analysis of benefits and associated risks. Digestion. 2007;75:156-63.
29. Choudhary A, Bechtold ML, Arif M, Szary NM, Puli SR, Othman MO, et al. Pancreatic stents for prophylaxis against post-ERCP pancreatitis: a meta-analysis and systematic review. Gastrointest Endosc. 2011;73:275-82.
30. Singh P, Das A, Isenberg G, Wong RCK, Sivak MV, Agrawal D, et al. Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis? A meta-analysis of controlled studies. Gastrointest Endosc. 2004;60:544-50.
31. Mazaki T, Masuda H, Takayama T. Prophylactic pancreatic stent placement and post-ERCP pancreatitis: a systematic review and meta-analysis. Endoscopy. 2010;42:842-52.
32. Cotton PB, Lehman G, Vennes J, Geenen JE, Russell RCG, Meyers WC, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc. 1991;37:383-93.
33. Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson CD, Sarr MG, et al. Classification of acute pancreatitis - 2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62:102-11.
34. Egger M. Meta-analysis in context, 2nd edn. London: BMJ Books.
35. Sutton AJ. Methods for meta-analysis in medical research. West Sussex: Wiley; 2002.
36. DerSimonian R, Laird N. Meta-analysis in clinical studies. Control Clin Stud. 1986;7:177-88.
37. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. Br Med J. 2003;327:557-60.
38. Ioannidis JP, Trikalinos TA. The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey. Can Med Assoc J. 2007;176:1091-6.
39. Masci E, Mariani A, Curioni S, Testoni PA. Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography: a meta-analysis. Endoscopy. 2003;35:830-4.
40. Das A, Singh P, Sivak MV, Chak A. Pancreatic-stent placement for prevention of post-ERCP pancreatitis: a cost-effectiveness analysis. Gastrointest Endosc. 2007;65:960-8.
41. Freeman ML. Pancreatic stents for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis. Clin Gastroenterol Hepatol. 2007;5:1354-65.
42. Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al. Does quality of reports of randomised studies affect estimates of intervention efficacy reported in meta-analyses? Lancet. 1998;352:609-13.
43. Jüni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical studies for meta-analysis. JAMA. 1999;282:1054-60.
44. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled studies. JAMA. 1995;273:408-12.
45. Bakman YG, Safdar K, Freemen ML. Significant clinical implication of prophylactic pancreatic stent placement in previously normal pancreatic ducts. Endoscopy. 2009;41:1095-8.
46. Price LH, Brandabur JJ, Kozarek RA, Gluck M, Traverso WL, Irani S. Good stents gone bad: endoscopic treatment of proximally migrated pancreatic duct stents. Gastrointest Endosc. 2009;70:174-9.